POST Online Media Lite Edition



 

NEWLY REPORTED COVID-19 CASES (11.19.2021, 4:50pm CEST, WHO):   India 11,106    Brazil 11,977    United Kingdom 46,858    Russia 37,156    Turkey 22,234    France 19,840    Argentina 1,553    Germany 52,970    Spain 3,932    Columbia 2,257    Italy 10,645    Mexico 3,836    Ukraine 20,050    Poland 23,242    Philippines 1,297    Malaysia 6,380    Netherlands 23,680    Peru 1,370    Thailand 6,855    Czechia 13,374    Canada 2,448    Romania 3,076    Chile 2,611    Serbia 3,219    Sweden 1,210    Portugal 2,398    Vietnam 10,223    Kazakhstan 1,272    Austria 14,212    Hungary 11,289    Greece 7,276    Georgia 4,278    Bulgaria 2,785    Belarus 1,844    Slovakia 7,418    Azerbaijan 2,124    Croatia 7,270    Bolivia 1,119    Ireland 4,646    Lithuania 1,847    Denmark 4,013    South Korea 3,034    Slovenia 3,662    Latvia 1,221    Laos 1,401    China 31    New Zealand 200    Australia 1,302   

Japan approves Pfizer COVID-19 vaccine for ages 12-15

Christian Fernsby |
The Japanese government on Monday approved Pfizer Inc.'s COVID-19 vaccine for 12- to 15-year-olds, the first shot to be made available to children in the country.

Article continues below




The age group will be able to receive shots free of charge in addition to those aged 16 and older already eligible, a health ministry panel decided at a meeting in the afternoon.

Children aged 12 to 15 will not immediately begin getting the Pfizer vaccine, as Japan is still in the process of inoculating health care workers and people aged 65 and older.

Only around 6 percent of the country's population of 126 million has been given at least one dose, a much lower share than other developed nations.


What to read next

Delaying second Pfizer vaccines to 12 weeks significantly increases antibody responses in older people
New vaccine to provide 2-year protection
WHO approves Sinopharm COVID-19 vaccine for emergency use